Ines Macias-Perez

Company: Cumberland Pharmaceuticals

Job title: Director, Product Development

Seminars:

Exploring the Interface Between Idiopathic Exploring the Regulatory Considerations for Clinical Trial Design when Evaluating Treatments for Idiopathic Pulmonary Fibrosis & Progressive Pulmonary Fibrosis 12:00 pm

• With the evolution of the field and new combinatory approach should we be looking at IPF and PPF in the same light? • What are the regulatory distinctions for IPF and PPF trial design? Should these be pursued as separate indications and run in parallel? • Is clinical design a cut and paste entity…Read more

day: Day Two Track B AM